XML 44 R31.htm IDEA: XBRL DOCUMENT
v3.25.3

Segment Reporting (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2025
Segment Reporting [Abstract] |
Summary of Reportable Revenues by Geographic Regions | The following table summarizes reportable revenue by geographic regions (in thousands):
| Three Months Ended September 30, |  | Nine Months Ended September 30,
| 2025 |  | 2024 |  | 2025 |  | 2024
Testing services revenue |  |  |  |  |  |  |
United States | $ | 72,073 |  |  | $ | 60,408 |  |  | $ | 195,181 |  |  | $ | 184,757 |
Rest of World | 95 |  |  | 399 |  |  | 941 |  |  | 805 |
| $ | 72,168 |  |  | $ | 60,807 |  |  | $ | 196,122 |  |  | $ | 185,562 |
Product revenue |  |  |  |  |  |  |
United States | $ | 7,593 |  |  | $ | 6,850 |  |  | $ | 21,293 |  |  | $ | 18,701 |
Rest of World | 4,885 |  |  | 3,362 |  |  | 13,828 |  |  | 10,715 |
| $ | 12,478 |  |  | $ | 10,212 |  |  | $ | 35,121 |  |  | $ | 29,416 |
Patient and digital solutions revenue |  |  |  |  |  |  |
United States | $ | 15,392 |  |  | $ | 11,824 |  |  | $ | 40,090 |  |  | $ | 32,102 |
Rest of World | 17 |  |  | 40 |  |  | 86 |  |  | 126 |
| $ | 15,409 |  |  | $ | 11,864 |  |  | $ | 40,176 |  |  | $ | 32,228 |
Total revenue |  |  |  |  |  |  |
Total United States | $ | 95,058 |  |  | $ | 79,082 |  |  | $ | 256,564 |  |  | $ | 235,560 |
Total Rest of World | 4,997 |  |  | 3,801 |  |  | 14,855 |  |  | 11,646 |
| $ | 100,055 |  |  | $ | 82,883 |  |  | $ | 271,419 |  |  | $ | 247,206 |
Summary of Long-Lived Assets Consisting of Property and Equipment, Net by Geographic Regions | The following table summarizes long-lived assets, consisting of property and equipment, net, by geographic regions (in thousands):
| September 30, 2025 |  | December 31, 2024
Long-lived assets: |  |  |
United States | $ | 30,612 |  |  | $ | 33,286 |
Rest of World | 233 |  |  | 266 |
Total | $ | 30,845 |  |  | $ | 33,552 |
Summary of Reconciliation of Revenue to Net Loss | The following table summarizes the reconciliation to net income (loss) (in thousands):
| Three Months Ended September 30, |  | Nine Months Ended September 30,
| 2025 |  | 2024 |  | 2025 |  | 2024
Revenue: |  |  |  |  |  |  |
Testing services revenue | $ | 72,168 |  |  | $ | 60,807 |  |  | $ | 196,122 |  |  | $ | 185,562 |
Product revenue | 12,478 |  |  | 10,212 |  |  | 35,121 |  |  | 29,416 |
Patient and digital solutions revenue | 15,409 |  |  | 11,864 |  |  | 40,176 |  |  | 32,228 |
Total revenue | 100,055 |  |  | 82,883 |  |  | 271,419 |  |  | 247,206 |
Less: |  |  |  |  |  |  |
Cost of testing services 1 | 14,058 |  |  | 12,700 |  |  | 43,192 |  |  | 39,168 |
Cost of product 1 | 5,131 |  |  | 5,559 |  |  | 14,505 |  |  | 15,828 |
Cost of patient and digital solutions 1 | 10,050 |  |  | 7,417 |  |  | 25,323 |  |  | 20,537 |
Personnel cost | 33,915 |  |  | 29,186 |  |  | 93,988 |  |  | 86,557 |
Professional and legal fees | 10,307 |  |  | 10,224 |  |  | 32,847 |  |  | 32,430 |
Research materials and clinical trials expense | 1,791 |  |  | 3,526 |  |  | 9,022 |  |  | 11,730 |
Depreciation and amortization expense | 3,020 |  |  | 3,040 |  |  | 8,921 |  |  | 9,526 |
Stock-based compensation expense | 8,418 |  |  | 16,923 |  |  | 26,773 |  |  | 49,895 |
Litigation settlement expense | — |  |  | — |  |  | 5,710 |  |  | — |
Transformational initiative costs 2 | 524 |  |  | — |  |  | 2,395 |  |  | — |
Other segment items 3 | 13,179 |  |  | 7,946 |  |  | 33,149 |  |  | 25,396 |
Interest income, net | (2,013) |  |  | (3,001) |  |  | (7,160) |  |  | (8,713) |
Segment and condensed consolidated net income (loss) | $ | 1,675 |  |  | $ | (10,637) |  |  | $ | (17,246) |  |  | $ | (35,148) |
1 Cost of testing services, cost of product and cost of patient and digital solutions include depreciation expense. 2 Transformational initiative costs consist of consulting expenses which relate to the Company's ongoing transformation strategy that the Company has undertaken as a series of initiatives focused on operational excellence, enterprise-wide efficiency, and long-term strategic growth, including rebranding costs. 3 Other segment items include the following: acquisition costs, software expenses, corporate expenses, rent and maintenance expense, travel and event related expense, one-time impairment charge on intangible asset and associated construction in progress, and other expenses (income).

X
- Definition Tabular disclosure of long-lived assets, excluding financial instruments, long-term customer relationships of a financial institution, mortgage rights, deferred policy acquisition costs, and deferred tax assets, by geographic areas located in the entity's country of domicile and foreign countries in which the entity holds assets. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 41 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41 + Details
Name: | us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 41 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41 + Details
Name: | us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration